Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Stelmach

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Clinical Lymphoma, Myeloma & Leukemia|July 11, 2020
Blinatumomab or Inotuzumab Ozogamicin as Bridge to Allogeneic Stem Cell Transplantation for Relapsed or Refractory B-lineage Acute Lymphoblastic Leukemia: A Retrospective Single-Center AnalysisPatrick Stelmach, Klaus Wethmar, Christoph Groth, et al.
Blood Advances|March 20, 2026
Telomere length and clonal hematopoiesis interact to influence outcomes in hematopoietic stem cell transplantationJake Tobin, Patrick Stelmach, Sarah Richter, et al.
Bone Marrow Transplantation|February 1, 2020
Monitoring minimal residual/relapsing disease after allogeneic haematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukaemiaKlaus Wethmar, Svenja Matern, Eva Eßeling, et al.
Haematologica|June 29, 2023
Clonal hematopoiesis with <i>DNMT3A</i> and <i>PPM1D</i> mutations impairs regeneration in autologous stem cell transplant recipientsPatrick Stelmach, Sarah Richter, Sandra Sauer, et al.
Blood|March 11, 2025
Clonal hematopoiesis landscape in frequent blood donorsDarja Karpova, Hector Huerga Encabo, Elisa Donato, et al.
Nature Genetics|November 26, 2024
Single-cell multiomics analysis reveals dynamic clonal evolution and targetable phenotypes in acute myeloid leukemia with complex karyotypeAino-Maija Leppä, Karen Grimes, Hyobin Jeong, et al.
Cell Stem Cell|April 25, 2023
Clonally resolved single-cell multi-omics identifies routes of cellular differentiation in acute myeloid leukemiaSergi Beneyto-Calabuig, Anne Kathrin Merbach, Jonas-Alexander Kniffka, et al.
Cancer Research|November 11, 2025
Response to Immune Checkpoint Blockade is Enhanced in the Presence of Hematopoietic TET2 InactivationVincent Rondeau, Suraj Bansal, Marco M Buttigieg, et al.
Nature Communications|November 29, 2024
Multiple myeloma long-term survivors exhibit sustained immune alterations decades after first-line therapyRaphael Lutz, Florian Grünschläger, Malte Simon, et al.
Nature Cancer|December 29, 2022
Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trialClaudia M Denkinger, Maike Janssen, Ulrike Schäkel, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Clinical Lymphoma, Myeloma & Leukemia|July 11, 2020
Blinatumomab or Inotuzumab Ozogamicin as Bridge to Allogeneic Stem Cell Transplantation for Relapsed or Refractory B-lineage Acute Lymphoblastic Leukemia: A Retrospective Single-Center AnalysisPatrick Stelmach, Klaus Wethmar, Christoph Groth, et al.
Blood Advances|March 20, 2026
Telomere length and clonal hematopoiesis interact to influence outcomes in hematopoietic stem cell transplantationJake Tobin, Patrick Stelmach, Sarah Richter, et al.
Bone Marrow Transplantation|February 1, 2020
Monitoring minimal residual/relapsing disease after allogeneic haematopoietic stem cell transplantation in adult patients with acute lymphoblastic leukaemiaKlaus Wethmar, Svenja Matern, Eva Eßeling, et al.
Haematologica|June 29, 2023
Clonal hematopoiesis with <i>DNMT3A</i> and <i>PPM1D</i> mutations impairs regeneration in autologous stem cell transplant recipientsPatrick Stelmach, Sarah Richter, Sandra Sauer, et al.
Blood|March 11, 2025
Clonal hematopoiesis landscape in frequent blood donorsDarja Karpova, Hector Huerga Encabo, Elisa Donato, et al.
Nature Genetics|November 26, 2024
Single-cell multiomics analysis reveals dynamic clonal evolution and targetable phenotypes in acute myeloid leukemia with complex karyotypeAino-Maija Leppä, Karen Grimes, Hyobin Jeong, et al.
Cell Stem Cell|April 25, 2023
Clonally resolved single-cell multi-omics identifies routes of cellular differentiation in acute myeloid leukemiaSergi Beneyto-Calabuig, Anne Kathrin Merbach, Jonas-Alexander Kniffka, et al.
Cancer Research|November 11, 2025
Response to Immune Checkpoint Blockade is Enhanced in the Presence of Hematopoietic TET2 InactivationVincent Rondeau, Suraj Bansal, Marco M Buttigieg, et al.
Nature Communications|November 29, 2024
Multiple myeloma long-term survivors exhibit sustained immune alterations decades after first-line therapyRaphael Lutz, Florian Grünschläger, Malte Simon, et al.
Nature Cancer|December 29, 2022
Anti-SARS-CoV-2 antibody-containing plasma improves outcome in patients with hematologic or solid cancer and severe COVID-19: a randomized clinical trialClaudia M Denkinger, Maike Janssen, Ulrike Schäkel, et al.
Pageof 2